The hypotheses to be tested are 1) Fiber supplementation will decrease the need for medication in patients with gestational diabetes, and 2) Fiber supplementation will decrease adverse maternal and neonatal outcomes in these patients. In this study, the investigators will conduct a randomized controlled trial to limit bias in evaluating these hypotheses.
Trial Locations
Loading…
Loading trial locations…
Facility
City
State
Country
Status
Eligibility Criteria
Inclusion Criteria:
* Singleton gestation
* Known or new diagnosis of gestational diabetes without reason for medication
* Age \>=18 to \<=50
Exclusion Criteria:
* \- Non-English as primary language.
* Known or suspected fetal anomaly or aneuploidy.
* Known lower bowel disorder
* Known phenylketo…
Inclusion Criteria:
* Singleton gestation
* Known or new diagnosis of gestational diabetes without reason for medication
* Age \>=18 to \<=50
Exclusion Criteria:
* \- Non-English as primary language.
* Known or suspected fetal anomaly or aneuploidy.
* Known lower bowel disorder
* Known phenylketonuria
* Prisoners.
* Management of diabetes outside of Eastern Virginia Medical School Maternal Fetal Medicine.
Contacts
No contact information available.
What are you hoping to find?
Picking one helps us show the most relevant trials first.
Your results are loading in the background — you can
change this any time from the results page.
Set your location to continue
Find My Trials uses your location to surface clinical trials near you.
Add your city or zip code to your profile and try again.